These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 23695422)

  • 41. The potential pathogenic role of IL-17/Th17 cells in both type 1 and type 2 diabetes mellitus.
    Abdel-Moneim A; Bakery HH; Allam G
    Biomed Pharmacother; 2018 May; 101():287-292. PubMed ID: 29499402
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Th17 Cells and the IL-23/IL-17 Axis in the Pathogenesis of Periodontitis and Immune-Mediated Inflammatory Diseases.
    Bunte K; Beikler T
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31295952
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anti-inflammatory or proinflammatory effect of an adenosine receptor agonist on the Th17 autoimmune response is inflammatory environment-dependent.
    Liang D; Zuo A; Shao H; Chen M; Kaplan HJ; Sun D
    J Immunol; 2014 Dec; 193(11):5498-505. PubMed ID: 25367119
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inflammasomes and rheumatic diseases: evolving concepts.
    Sidiropoulos PI; Goulielmos G; Voloudakis GK; Petraki E; Boumpas DT
    Ann Rheum Dis; 2008 Oct; 67(10):1382-9. PubMed ID: 17921182
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Defining the human T helper 17 cell phenotype.
    Annunziato F; Cosmi L; Liotta F; Maggi E; Romagnani S
    Trends Immunol; 2012 Oct; 33(10):505-12. PubMed ID: 22682163
    [TBL] [Abstract][Full Text] [Related]  

  • 46. IL-17 and IL-17R: an auspicious therapeutic target for psoriatic disease.
    Mitra A; Raychaudhuri SK; Raychaudhuri SP
    Actas Dermosifiliogr; 2014 Oct; 105 Suppl 1():21-33. PubMed ID: 25398489
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Molecular effects of physical therapy. What's new?].
    Lange U; Tarner IH; Dischereit G; Müller-Ladner U
    Z Rheumatol; 2015 Apr; 74(3):226-9. PubMed ID: 25854157
    [TBL] [Abstract][Full Text] [Related]  

  • 48. IK acts as an immunoregulator of inflammatory arthritis by suppressing T
    Park HL; Lee SM; Min JK; Moon SJ; Kim I; Kang KW; Park S; Choi S; Jung HN; Lee DH; Nam JH
    Sci Rep; 2017 Jan; 7():40280. PubMed ID: 28071693
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Trim33 mediates the proinflammatory function of Th17 cells.
    Tanaka S; Jiang Y; Martinez GJ; Tanaka K; Yan X; Kurosaki T; Kaartinen V; Feng XH; Tian Q; Wang X; Dong C
    J Exp Med; 2018 Jul; 215(7):1853-1868. PubMed ID: 29930104
    [TBL] [Abstract][Full Text] [Related]  

  • 50. TH1 and TH17 interactions in untreated inflamed mucosa of inflammatory bowel disease, and their potential to mediate the inflammation.
    Olsen T; Rismo R; Cui G; Goll R; Christiansen I; Florholmen J
    Cytokine; 2011 Dec; 56(3):633-40. PubMed ID: 21945121
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Th17 cytokines differentiate obesity from obesity-associated type 2 diabetes and promote TNFα production.
    Ip B; Cilfone NA; Belkina AC; DeFuria J; Jagannathan-Bogdan M; Zhu M; Kuchibhatla R; McDonnell ME; Xiao Q; Kepler TB; Apovian CM; Lauffenburger DA; Nikolajczyk BS
    Obesity (Silver Spring); 2016 Jan; 24(1):102-12. PubMed ID: 26576827
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Th17 cells in autoimmune diseases.
    Han L; Yang J; Wang X; Li D; Lv L; Li B
    Front Med; 2015 Mar; 9(1):10-9. PubMed ID: 25652649
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dysregulation of proinflammatory versus anti-inflammatory human T
    Noster R; de Koning HD; Maier E; Prelog M; Lainka E; Zielinski CE
    J Allergy Clin Immunol; 2016 Oct; 138(4):1161-1169.e6. PubMed ID: 27040374
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Medroxyprogesterone Acetate Decreases Th1, Th17, and Increases Th22 Responses via AHR Signaling Which Could Affect Susceptibility to Infections and Inflammatory Disease.
    Piccinni MP; Lombardelli L; Logiodice F; Kullolli O; Maggi E; Barkley MS
    Front Immunol; 2019; 10():642. PubMed ID: 31001262
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Th17 cells associated cytokines and cancer.
    Feng S; Chen XM; Wang JF; Xu XQ
    Eur Rev Med Pharmacol Sci; 2016 Oct; 20(19):4032-4040. PubMed ID: 27775796
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gut Commensal-Induced IκBζ Expression in Dendritic Cells Influences the Th17 Response.
    Michaelis L; Treß M; Löw HC; Klees J; Klameth C; Lange A; Grießhammer A; Schäfer A; Menz S; Steimle A; Schulze-Osthoff K; Frick JS
    Front Immunol; 2020; 11():612336. PubMed ID: 33542719
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mouse T helper 17 phenotype: not so different than in man after all.
    Annunziato F; Romagnani S
    Cytokine; 2011 Oct; 56(1):112-5. PubMed ID: 21813287
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Loss of Smad7 Promotes Inflammation in Rheumatoid Arthritis.
    Zhou G; Sun X; Qin Q; Lv J; Cai Y; Wang M; Mu R; Lan HY; Wang QW
    Front Immunol; 2018; 9():2537. PubMed ID: 30450102
    [No Abstract]   [Full Text] [Related]  

  • 59. Targeting interleukin-17 in chronic inflammatory disease: A clinical perspective.
    Zwicky P; Unger S; Becher B
    J Exp Med; 2020 Jan; 217(1):. PubMed ID: 31727781
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies.
    Maddur MS; Miossec P; Kaveri SV; Bayry J
    Am J Pathol; 2012 Jul; 181(1):8-18. PubMed ID: 22640807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.